Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynen

Showing results (541-550 of 624) with videos related to

Pageof 63
Sort By:
Plos One|January 8, 2020
Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015Richard Makurumidze, Tsitsi Mutasa-Apollo, Tom Decroo, et al.
AIDS Research and Therapy|July 9, 2022
Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018Trudy Tholakele Mhlanga, Bart K M Jacobs, Tom Decroo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2015
The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the FieldJohan van Griensven, Anja De Weiggheleire, Alexandre Delamou, et al.
Plos One|May 19, 2020
The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistanceArmand Van Deun, Tom Decroo, Aung Kya Jai Maug, et al.
Physical Review Letters|September 16, 2000
Fragment kinetic energies and modes of fragment formationOdeh, Bassini, Begemann-Blaich, et al.
Plos One|November 30, 2021
Long-term retention and predictors of attrition for key populations receiving antiretroviral treatment through community-based ART in Benue State Nigeria: A retrospective cohort studyOlujuwon Ibiloye, Plang Jwanle, Caroline Masquillier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 25, 2009
An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in CambodiaLutgarde Lynen, Sokkab An, Olivier Koole, et al.
Physical Chemistry Chemical Physics : PCCP|November 29, 2012
Quantification of silanol sites for the most common mesoporous ordered silicas and organosilicas: total versus accessible silanolsMatthias Ide, Mohamad El-Roz, Els De Canck, et al.
Physical Review. C, Nuclear Physics|August 1, 1993
Quantum molecular dynamics simulation of multifragment production in heavy ion collisions at E/A=600 MeVBegemann-Blaich, Müller, Aichelin, et al.
AIDS (London, England)|August 30, 2008
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switchingJulian H Elliott, Lut Lynen, Alexandra Calmy, et al.
Pageof 63

Showing results (541-550 of 624) with videos related to

Sort By:
Pageof 63
Plos One|January 8, 2020
Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015Richard Makurumidze, Tsitsi Mutasa-Apollo, Tom Decroo, et al.
AIDS Research and Therapy|July 9, 2022
Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018Trudy Tholakele Mhlanga, Bart K M Jacobs, Tom Decroo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2015
The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the FieldJohan van Griensven, Anja De Weiggheleire, Alexandre Delamou, et al.
Plos One|May 19, 2020
The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistanceArmand Van Deun, Tom Decroo, Aung Kya Jai Maug, et al.
Physical Review Letters|September 16, 2000
Fragment kinetic energies and modes of fragment formationOdeh, Bassini, Begemann-Blaich, et al.
Plos One|November 30, 2021
Long-term retention and predictors of attrition for key populations receiving antiretroviral treatment through community-based ART in Benue State Nigeria: A retrospective cohort studyOlujuwon Ibiloye, Plang Jwanle, Caroline Masquillier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 25, 2009
An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in CambodiaLutgarde Lynen, Sokkab An, Olivier Koole, et al.
Physical Chemistry Chemical Physics : PCCP|November 29, 2012
Quantification of silanol sites for the most common mesoporous ordered silicas and organosilicas: total versus accessible silanolsMatthias Ide, Mohamad El-Roz, Els De Canck, et al.
Physical Review. C, Nuclear Physics|August 1, 1993
Quantum molecular dynamics simulation of multifragment production in heavy ion collisions at E/A=600 MeVBegemann-Blaich, Müller, Aichelin, et al.
AIDS (London, England)|August 30, 2008
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switchingJulian H Elliott, Lut Lynen, Alexandra Calmy, et al.
Pageof 63